Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

<p>WOODCLIFF LAKE, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) &#8212; Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (the “Company”) today announced that it received a notice (the “Notice”) on November 27, 2023 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it is not currently in compliance with Nasdaq’s continued listing [&#8230;]</p>
<p>The post <a href="https://forextv.com/top-news/eagle-pharmaceuticals-announces-receipt-of-notification-of-deficiency-from-nasdaq-regarding-requirement-to-timely-file-quarterly-report-on-form-10-q/">Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>